Endothelial glycocalyx damage in patients with severe COVID-19 on mechanical ventilation - A prospective observational pilot study
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články, pozorovací studie
PubMed
35342082
DOI
10.3233/ch-221401
PII: CH221401
Knihovny.cz E-zdroje
- Klíčová slova
- glycocalyx, pneumonia, sepsis,
- MeSH
- biologické markery MeSH
- COVID-19 * patologie MeSH
- endoteliální buňky * patologie MeSH
- glykokalyx * metabolismus MeSH
- lidé středního věku MeSH
- lidé MeSH
- pilotní projekty MeSH
- prospektivní studie MeSH
- senioři MeSH
- syndekan-1 metabolismus MeSH
- umělé dýchání MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- pozorovací studie MeSH
- Názvy látek
- biologické markery MeSH
- syndekan-1 MeSH
BACKGROUND: Coronavirus disease (COVID-19) associated endotheliopathy and microvascular dysfunction are of concern. OBJECTIVE: The objective of the present single-center observational pilot study was to compare endothelial glycocalyx (EG) damage and endotheliopathy in patients with severe COVID-19 (COVID-19 group) with patients with bacterial pneumonia with septic shock (non-COVID group). METHODS: Biomarkers of EG damage (syndecan-1), endothelial cells (EC) damage (thrombomodulin), and activation (P-selectin) were measured in blood on three consecutive days from admission to the intensive care unit (ICU). The sublingual microcirculation was studied by Side-stream Dark Field (SDF) imaging with automatic assessment. RESULTS: We enrolled 13 patients in the non-COVID group (mean age 70 years, 6 women), and 15 in the COVID-19 group (64 years old, 3 women). The plasma concentrations of syndecan-1 were significantly higher in the COVID-19 group during all three days. Differences regarding other biomarkers were not statistically significant. The assessment of the sublingual microcirculation showed improvement on Day 2 in the COVID-19 group. Plasma levels of C-reactive protein (CRP) were significantly higher on the first two days in the COVID-19 group. Plasma syndecan-1 and CRP were higher in patients suffering from severe COVID-19 pneumonia compared to bacterial pneumonia patients. CONCLUSIONS: These findings support the role of EG injury in the microvascular dysfunction in COVID-19 patients who require ICU.
1st Department of Anaesthesia and Intensive Therapy Medical University of Lublin Lublin Poland
Center for Research and Development University Hospital Hradec Kralove Hradec Kralove Czech Republic
Department of Microbiology and Immunology Dalhousie University Halifax NS Canada
Department of Pharmacology Dalhousie University Halifax NS Canada
Department of Physiology and Biophysics Dalhousie University Halifax NS Canada
Faculty of Medicine in Hradec Kralove Charles University Hradec Kralove Czech Republic
International Fluid Academy Lovenjoel Belgium
Karolinska Institutet at Danderyds Hospital Stockholm Sweden
Citace poskytuje Crossref.org